Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 3 |
2020 | 1 |
2021 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic HSV Vectors and Anti-Tumor Immunity.
Curr Issues Mol Biol. 2021;41:381-468. doi: 10.21775/cimb.041.381. Epub 2020 Sep 17.
Curr Issues Mol Biol. 2021.
PMID: 32938804
Free article.
Review.
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.
Raphael I, Kumar R, McCarl LH, Shoger K, Wang L, Sandlesh P, Sneiderman CT, Allen J, Zhai S, Campagna ML, Foster A, Bruno TC, Agnihotri S, Hu B, Castro BA, Lieberman FS, Broniscer A, Diaz AA, Amankulor NM, Rajasundaram D, Pollack IF, Kohanbash G.
Raphael I, et al.
Front Immunol. 2021 May 7;12:637146. doi: 10.3389/fimmu.2021.637146. eCollection 2021.
Front Immunol. 2021.
PMID: 34025646
Free PMC article.
Item in Clipboard
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.
Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, Kumasaka D, Pierce RH, Weller M, Finer M, Quéva C, Glorioso JC, Houghton AM, Holland EC.
Wirsching HG, et al.
JCI Insight. 2019 Jul 11;4(13):e128217. doi: 10.1172/jci.insight.128217. eCollection 2019 Jul 11.
JCI Insight. 2019.
PMID: 31292299
Free PMC article.
Item in Clipboard
Novel mutations in UL24 and gH rescue efficient infection of an HSV vector retargeted to TrkA.
Marzulli M, Hall BL, Zhang M, Goins WF, Cohen JB, Glorioso JC.
Marzulli M, et al.
Mol Ther Methods Clin Dev. 2023 Jul 3;30:208-220. doi: 10.1016/j.omtm.2023.06.012. eCollection 2023 Sep 14.
Mol Ther Methods Clin Dev. 2023.
PMID: 37519407
Free PMC article.
Item in Clipboard
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment.
Jackson JW, Hall BL, Marzulli M, Shah VK, Bailey L, Chiocca EA, Goins WF, Kohanbash G, Cohen JB, Glorioso JC.
Jackson JW, et al.
Mol Ther Oncolytics. 2021 Jul 29;22:444-453. doi: 10.1016/j.omto.2021.07.009. eCollection 2021 Sep 24.
Mol Ther Oncolytics. 2021.
PMID: 34553031
Free PMC article.
Item in Clipboard
Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9.
Wirsching HG, Arora S, Zhang H, Szulzewsky F, Cimino PJ, Quéva C, Houghton AM, Glorioso JC, Weller M, Holland EC.
Wirsching HG, et al.
Neuro Oncol. 2019 Dec 17;21(12):1607-1609. doi: 10.1093/neuonc/noz145.
Neuro Oncol. 2019.
PMID: 31412117
Free PMC article.
No abstract available.
Item in Clipboard
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.
Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P.
Sette P, et al.
Mol Ther Oncolytics. 2019 Oct 24;15:214-222. doi: 10.1016/j.omto.2019.10.005. eCollection 2019 Dec 20.
Mol Ther Oncolytics. 2019.
PMID: 31890868
Free PMC article.
Item in Clipboard
Cite
Cite